Science Explorer Back to mapMap
Discussion
Company · Matsumoto · Japan

Kissei Pharmaceutical (Japan)

In research, Kissei Pharmaceutical (Japan) stands highest in Biochemistry, Genetics and Molecular Biology (#4,831 of 5,801 worldwide), Life Sciences (#9,644 of 11,023 worldwide) and Medicine (#13,199 of 14,558 worldwide), over all time.

kissei.co.jp/e_contents/index.htmlROR OpenAlex
World rank, all time
#32,547
of 34,923
Rank in Japan
#1,592
of 1,923
Research works
578
▼ 4% vs 2018-21
Citations
13k
22.7 per fractional work
Top-10% rate
1.7%
all institutions 10.0%
vs its own fields
0.73×
1.00× is exactly expected
Open access
54%
world 40%
International
8%
world 18%
Kissei Pharmaceutical (Japan)

What is Kissei Pharmaceutical (Japan) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Biochemistry, Genetics and Molecular BiologyField #4,831 of 5,801 6.2%122
Life SciencesDomain #9,644 of 11,023 5.5%226
MedicineField #13,199 of 14,558 4.8%262
Health SciencesDomain #15,373 of 16,688 4.9%275

Each strip is that field's whole ranked pool, with the notch where Kissei Pharmaceutical (Japan) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Kissei Pharmaceutical (Japan) work in?

In 2022-now, 59% of research at Kissei Pharmaceutical (Japan) is in Health Sciences, 34% in Life Sciences. Its largest fields are Medicine (59%), Biochemistry, Genetics and Molecular Biology (14%), Neuroscience (12%). It does 2.1× the world's share of Health Sciences.

Health Sciences: 18 fractional works · 59.0% of its workMedicine: 18 fractional works · 58.8% of its workUrology: 3 fractional works · 8.5% of its workPhysiology: 2 fractional works · 6.6% of its workReproductive Medicine: 2 fractional works · 6.5% of its workRheumatology: 2 fractional works · 5.0% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 4.3% of its workNephrology: 1 fractional works · 4.3% of its workEpidemiology: 1 fractional works · 3.5% of its workNeurology: 1 fractional works · 3.0% of its workPulmonary and Respiratory Medicine: 1 fractional works · 3.0% of its workObstetrics and Gynecology: 1 fractional works · 2.2% of its workPathology and Forensic Medicine: 1 fractional works · 2.1% of its workSurgery: 0 fractional works · 1.5% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.4% of its workDermatology: 0 fractional works · 1.3% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.1% of its workHematology: 0 fractional works · 1.1% of its workOphthalmology: 0 fractional works · 0.8% of its workGastroenterology: 0 fractional works · 0.8% of its workPharmacology: 0 fractional works · 0.6% of its workPsychiatry and Mental health: 0 fractional works · 0.6% of its workOncology: 0 fractional works · 0.4% of its workGenetics: 0 fractional works · 0.3% of its workVeterinary: 0 fractional works · 0.2% of its workSmall Animals: 0 fractional works · 0.2% of its workLife Sciences: 10 fractional works · 34.0% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 13.6% of its workMolecular Biology: 2 fractional works · 6.0% of its workGenetics: 2 fractional works · 5.7% of its workCell Biology: 0 fractional works · 1.1% of its workMolecular Medicine: 0 fractional works · 0.8% of its workNeuroscience: 4 fractional works · 12.1% of its workCellular and Molecular Neuroscience: 1 fractional works · 4.5% of its workSensory Systems: 1 fractional works · 2.9% of its workBehavioral Neuroscience: 1 fractional works · 2.2% of its workEndocrine and Autonomic Systems: 1 fractional works · 2.2% of its workCognitive Neuroscience: 0 fractional works · 0.4% of its workImmunology and Microbiology: 1 fractional works · 4.5% of its workImmunology: 1 fractional works · 4.5% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 3.8% of its workPharmaceutical Science: 1 fractional works · 1.9% of its workPharmacology: 0 fractional works · 1.5% of its workToxicology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPhysical Sciences: 2 fractional works · 6.9% of its workChemistry: 1 fractional works · 4.0% of its workOrganic Chemistry: 1 fractional works · 2.2% of its workSpectroscopy: 0 fractional works · 1.4% of its workPhysical and Theoretical Chemistry: 0 fractional works · 0.4% of its workEngineering: 0 fractional works · 1.3% of its workMechanical Engineering: 0 fractional works · 0.7% of its workAerospace Engineering: 0 fractional works · 0.4% of its workControl and Systems Engineering: 0 fractional works · 0.2% of its workComputer Science: 0 fractional works · 0.6% of its workComputational Theory and Mathematics: 0 fractional works · 0.6% of its workMaterials Science: 0 fractional works · 0.6% of its workPolymers and Plastics: 0 fractional works · 0.6% of its workMathematics: 0 fractional works · 0.5% of its workStatistics and Probability: 0 fractional works · 0.5% of its workSocial Sciences: 0 fractional works · 0.1% of its workSocial Sciences: 0 fractional works · 0.1% of its workALL ITS WORKKisseiPharmaceutical…31fractional works, 2022-now
Life Sciences34%Physical Sciences7%Health Sciences59%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 12 fields, with their numbers
    1. Medicine1858.8%
    2. Veterinary00.2%
    1. Biochemistry, Genetics and Molecular Biology413.6%
    2. Neuroscience412.1%
    3. Immunology and Microbiology14.5%
    4. Pharmacology, Toxicology and Pharmaceutics13.8%
    1. Chemistry14.0%
    2. Engineering01.3%
    3. Computer Science00.6%
    4. Materials Science00.6%
    5. Mathematics00.5%
    1. Social Sciences00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.56× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 4.48× its world share, 1 worksImmunology and Micro…Neuroscience: 7.46× its world share, 4 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 10.63× its world share, 1 worksPharmacology, Toxico…Chemistry: 2.53× its world share, 1 worksChemistryComputer Science: 0.07× its world share, 0 worksComputer ScienceEngineering: 0.09× its world share, 0 worksEngineeringMaterials Science: 0.15× its world share, 0 worksMaterials ScienceMathematics: 0.43× its world share, 0 worksMathematicsMedicine: 3.06× its world share, 18 worksMedicineVeterinary: 1.59× its world share, 0 worksVeterinarySocial Sciences: 0.01× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 10.6×. Every wedge is a field page.

All 12 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics10.63×1 works
  2. Neuroscience7.46×4 works
  3. Immunology and Microbiology4.48×1 works
  4. Medicine3.06×18 works
  5. Biochemistry, Genetics and Molecular Biology2.56×4 works
  6. Chemistry2.53×1 works
  7. Veterinary1.59×0 works
  8. Mathematics0.43×0 works
  9. Materials Science0.15×0 works
  10. Engineering0.09×0 works
  11. Computer Science0.07×0 works
  12. Social Sciences0.01×0 works

Who are the top researchers at Kissei Pharmaceutical (Japan)?

Ranked on the quality score, Kenji Akahane, Kenji Katsuno and Masayuki Isaji lead among researchers whose main affiliation is Kissei Pharmaceutical (Japan).

  1. 1 Kenji Akahane Japan · #2,244,633 worldwide 772 citations · 34 works
  2. 2 Kenji Katsuno Japan · #2,746,727 worldwide 1.2k citations · 22 works
  3. 3 Masayuki Isaji Japan · #2,890,410 worldwide 2k citations · 52 works
  4. 4 Kazuhiko Shinagawa Japan · #3,451,225 worldwide 1.4k citations · 23 works
  5. 5 Kinji Iizuka Japan · #3,966,118 worldwide 1k citations · 33 works
  6. 6 Masahiro Hiratochi Japan · #4,224,258 worldwide 741 citations · 17 works
  7. 7 Hiromu Harada Japan · #4,522,204 worldwide 608 citations · 31 works
  8. 8 Yukiyoshi Ajisawa Japan · #4,589,607 worldwide 1.1k citations · 32 works
  9. 9 Noriyasu Saito Japan · #4,921,263 worldwide 324 citations · 24 works
  10. 10 Motohiro Tezuka Japan · #4,929,692 worldwide 117 citations · 15 works
All ranked researchers at Kissei Pharmaceutical (Japan)

What are the most cited papers from Kissei Pharmaceutical (Japan)?

The most cited paper from Kissei Pharmaceutical (Japan) is "Execution of Apoptosis Signal-regulating Kinase 1 (ASK1)-induced Apoptosis by the Mitochondria-dependent Caspase Activation" (Takiko Hatai, Atsushi Matsuzawa, Seiji Inoshita et al., 2000), with 334 citations. Next come "Advanced Glycation End Products-driven Angiogenesis in Vitro" (276) and "Intramolecular Nonbonded S···O Interaction Recognized in (Acylimino)thiadiazoline Derivatives as Angiotensin II Receptor Antagonists and Related Compounds" (271).

Most cited papers
#PaperReleasedCitations
1 Execution of Apoptosis Signal-regulating Kinase 1 (ASK1)-induced Apoptosis by the Mitochondria-dependent Caspase Activation Takiko Hatai, Atsushi Matsuzawa, Seiji Inoshita et al. · Journal of Biological Chemistry Open access Aug 2000 334
2 Advanced Glycation End Products-driven Angiogenesis in Vitro Sho‐ichi Yamagishi, Hideto Yonekura, Yasuhiko Yamamoto et al. · Journal of Biological Chemistry Open access Mar 1997 276
3 Intramolecular Nonbonded S···O Interaction Recognized in (Acylimino)thiadiazoline Derivatives as Angiotensin II Receptor Antagonists and Related Compounds Yoshimitsu Nagao, Terukage Hirata, Satoru Goto et al. · Journal of the American Chemical Society 20 Mar 1998 271
4 Sergliflozin, a Novel Selective Inhibitor of Low-Affinity Sodium Glucose Cotransporter (SGLT2), Validates the Critical Role of SGLT2 in Renal Glucose Reabsorption and Modulates Plasma Glucose Level Kenji Katsuno, Yoshikazu Fujimori, Yukiko Takemura et al. · Journal of Pharmacology and Experimental Therapeutics 18 Oct 2006 267
5 Physiological Roles of ASK1-Mediated Signal Transduction in Oxidative Stress- and Endoplasmic Reticulum Stress-Induced Apoptosis: Advanced Findings from ASK1 Knockout Mice Atsushi Matsuzawa, Hideki Nishitoh, Kei Tobiume et al. · Antioxidants and Redox Signaling Jun 2002 252
All 59 most cited papers, with filters and sorting

Which keywords describe research at Kissei Pharmaceutical (Japan)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Urinary Incontinence, Epidemiology, Mitochondrial Dysfunction, Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms, Insulin Resistance, Quality of Life and Metabolic Regulation.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 31 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 31 words, with their numbers
  1. Epidemiology4▲ 3.6×10 topics
  2. Urinary Incontinence4▲ 160×2 topics
  3. Mitochondrial Dysfunction3▲ 31×4 topics
  4. Benign Prostatic Hyperplasia3▲ 259×1 topic
  5. Lower Urinary Tract Symptoms3▲ 259×1 topic
  6. Insulin Resistance2▲ 18×3 topics
  7. Quality of Life2▲ 5.3×4 topics
  8. Metabolic Regulation2▲ 39×2 topics
  9. Surgical Treatment2▲ 33×2 topics
  10. Oxidative Stress2▲ 3.6×5 topics
  11. Brown Adipose Tissue2▲ 111×1 topic
  12. Thermogenesis2▲ 111×1 topic
  13. Diagnosis2▲ 5.6×7 topics
  14. Cardiovascular Disease1▲ 3.8×4 topics
  15. Inflammation1▲ 2.1×8 topics
  16. Genetics1▲ 5.8×4 topics
  17. Infertility1▲ 30×2 topics
  18. Pelvic Floor Dysfunction1▲ 90×1 topic
  19. Pelvic Organ Prolapse1▲ 90×1 topic
  20. Stress1▲ 12×3 topics
  21. Biomarkers1▲ 5.4×3 topics
  22. Depression1▲ 4.3×2 topics
  23. Pathophysiology1▲ 13×3 topics
  24. Signaling1▲ 60×2 topics
  25. Chronic Kidney Disease1▲ 13×2 topics
  26. Differentiated Thyroid Cancer1▲ 82×1 topic
  27. Estrogen1▲ 80×1 topic
  28. Management1▲ 4.2×4 topics
  29. Metabolic Syndrome1▲ 4.0×2 topics
  30. Receptor1▲ 100×1 topic
  31. Thyroid Nodules1▲ 82×1 topic

Which research topics does Kissei Pharmaceutical (Japan) publish most on?

By volume in 2022-now: Urinary Bladder and Prostate Research, Adipose Tissue and Metabolism, Pelvic floor disorders treatments and Estrogen and related hormone effects.

Urinary Bladder and Pros…3Urinary Bladder and Prostate Research: 3 fractional worksAdipose Tissue and Metabolism: 2 fractional worksPelvic floor disorders treatments: 1 fractional worksEstrogen and related hormone effects: 1 fractional worksThyroid Cancer Diagnosis and Treatment: 1 fractional worksUrinary Tract Infections…1Urinary Tract Infections Management: 1 fractional worksIon Channels and Receptors: 1 fractional worksEndometriosis Research and Treatment: 1 fractional worksHypothalamic control of reproductive hormones: 1 fractional worksAcute Kidney Injury Research: 1 fractional works
UrologyPhysiologyRheumatologyGenetics5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Urinary Bladder and Prostate Research Urology 3 works
  2. 2 Adipose Tissue and Metabolism Physiology 2 works
  3. 3 Pelvic floor disorders treatments Rheumatology 1 works
  4. 4 Estrogen and related hormone effects Genetics 1 works
  5. 5 Thyroid Cancer Diagnosis and Treatment Endocrinology, Diabetes and Metabolism 1 works
  6. 6 Urinary Tract Infections Management Epidemiology 1 works
  7. 7 Ion Channels and Receptors Sensory Systems 1 works
  8. 8 Endometriosis Research and Treatment Reproductive Medicine 1 works
  9. 9 Hypothalamic control of reproductive hormones Reproductive Medicine 1 works
  10. 10 Acute Kidney Injury Research Nephrology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.7%not open46.3%

World: 40% of research is openly available.

with international co-authors8.1%domestic only91.9%

World: 18% is written across borders.

How has Kissei Pharmaceutical (Japan)'s research output changed?

Output in 2022-2025 was 4% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Kissei Pharmaceutical (Japan) as a percentage of every work published that year, 0.00011% in 2024.

still counting0.0020%0.0040%Kissei Pharmaceutical (Japan)0.000067% in 202519801990200020102020

Fractional works of Kissei Pharmaceutical (Japan) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

5%10%15%all institutions10.0% in 2006Kissei Pharmaceutical (Japan)9.1% in 20062000

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 9.5% in 1990.

Other research institutions in Matsumoto

All research institutions in Matsumoto

Share Kissei Pharmaceutical (Japan)'s ranking

Kissei Pharmaceutical (Japan) on Science Explorer

A card with Kissei Pharmaceutical (Japan)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Kissei Pharmaceutical (Japan). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.